| HE4在卵巢上皮性癌早期诊断及病情监测中的价值 |
Alternative Title | Diagnostic and Prognostic Value of Serum HE4 in Patients with Epithelial Ovarian Cancer
|
| 宋晓玲 |
Thesis Advisor | 杨毓琴
|
| 2012-05-17
|
Degree Grantor | 兰州大学
|
Place of Conferral | 兰州
|
Degree Name | 硕士
|
Keyword | 卵巢上皮性癌
肿瘤标志物
早期诊断
|
Abstract | 目的 本实验应用ELISA方法检测卵巢肿瘤患者及健康体检者HE4水平,结合临床资料回顾分析,探讨HE4在卵巢癌尤其是早期卵巢癌诊断及病情监测中的意义。
方法 选择2010年07月至2011年07月甘肃省人民医院妇科住院的卵巢癌初治患者36例,卵巢良性肿瘤患者48例,健康体检中心健康女性体检者32例。应用双抗夹心法检测HE4和CA125水平。
结论
1卵巢癌患者HE4水平明显高于良性卵巢肿瘤及健康女性;卵巢癌患者HE4水平与患者的病理分期有关。
2 HE4诊断卵巢癌有较高的特异性和敏感性,对卵巢癌与卵巢良性肿瘤鉴别诊断的特异性相比CA125高,有望成为诊断卵巢癌的血清肿瘤标记物
3术后的卵巢癌患者HE4水平较术前明显降低,HE4作为卵巢癌疗效评价及病情监测具有可行性。 |
Other Abstract | Objectives:In this experimental,serum HE4 was determined by enzyme-linked immunosorbent assay in samples from overian tumor patients and healthy female volunteers.
Methods: We recruited 36 primary epithelial ovarian cancer patients,48 patients of ovarian benign masses and 32 healthy volunteers during July 2010 to July 2011 from the gynecology-oncology
1 ovarian cancer were higher than the group of benign ovarian tumors and healthy volunteers. However, the HE4 was no significant difference between ovarian benign tumor patients and healthy volunteers.
2 It is no sinificant difference between the histologic subtypes of ovarian cancer.
3 The serum HE4 values measured in stage Ⅲ-ⅣEOC patients were higher than in stage Ⅰ-Ⅱ EOC patients.
Conclusions:
1 Serum HE4 level that was evaluated by ELISA kit of overian cancer were higher than in benign overian tumors and healthy volunteers.
2 serum HE4 has a higher sensitivity and specificity than CA125.
3 The serum HE4 after surgery was significantly lower compared with preoperative.
Key words: Epithelial ovarian cancer, tumor marker,early diagnosis |
URL | 查看原文
|
Language | 中文
|
Document Type | 学位论文
|
Identifier | https://ir.lzu.edu.cn/handle/262010/224108
|
Collection | 学院待认领
|
Affiliation | 临床医学院
|
Recommended Citation GB/T 7714 |
宋晓玲. HE4在卵巢上皮性癌早期诊断及病情监测中的价值[D]. 兰州. 兰州大学,2012.
|
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.